CDx Beyond Oncology: Expanding into Rare Diseases and Neurodegenerative Disorders – New Market Frontiers
Companion diagnostics (CDx) are transcending their oncology roots, expanding into new disease areas like rare genetic disorders and neurodegenerative conditions, where precise patient stratification is critical. This shift is driven by advancements in biomarker discovery and growing demand for personalized treatments in underserved fields. As CDx proves its utility beyond cancer, the market is...
0 Commenti 0 condivisioni 117 Views 0 Anteprima
MTSocial https://mtsocial.ir